Survival benefit of radiation in high-risk, early-stage endometrioid carcinoma.
CONCLUSIONS: High-risk, early-stage endometrioid carcinoma is a heterogeneous population. BT was associated with a survival benefit in stage IB grade 3, whereas regional treatment with EBRT and lymphadenectomy was associated with a survival benefit in stage II grade 3.
PMID: 31912686 [PubMed - as supplied by publisher]
Source: Journal of Gynecologic Oncology - Category: OBGYN Tags: J Gynecol Oncol Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Endometrial Cancer | External Beam Therapy | Hysterectomy | Medicare | OBGYN | Radiation Therapy